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Electrically active constructs can have a beneficial effect on electroresponsive tissues, such as the brain, heart, and
nervous system. Conducting polymers (CPs) are being considered as components of these constructs because of
their intrinsic electroactive and flexible nature. However, their clinical application has been largely hampered by
their short operational time due to a decrease in their electronic properties. We show that, by immobilizing the
dopant in the conductive scaffold, we can prevent its electric deterioration. We grew polyaniline (PANI) doped with
phytic acid on the surface of a chitosan film. The strong chelation between phytic acid and chitosan led to a con-
ductive patch with retained electroactivity, low surface resistivity (35.85 ± 9.40 kilohms per square), and oxidized
form after 2 weeks of incubation in physiological medium. Ex vivo experiments revealed that the conductive nature
of the patch has an immediate effect on the electrophysiology of the heart. Preliminary in vivo experiments showed
that the conductive patch does not induce proarrhythmogenic activities in the heart. Our findings set the foundation
for the design of electronically stable CP-based scaffolds. This provides a robust conductive system that could be
used at the interface with electroresponsive tissue to better understand the interaction and effect of these materials
on the electrophysiology of these tissues.://
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Among the conductive materials used in bioelectronics, conducting
polymers (CPs) have attracted much attention over recent years be-
cause of their ability to conduct both electronically and ionically (1),
to be processed into scaffolds (2), and to be rendered biodegradable
(3, 4). In tissue engineering, bioelectronic devices are being developed
with the anticipation of reestablishing communication between
interrupted cells. Low-resistance pathways in excitable tissues, such as
the heart, nerves, andmuscles, permit rapid cell-to-cell communication
via currents generated by the flow of ions between neighboring cells.
These low-resistance pathways are critical for the proper function of ex-
citable tissues, for example, electrically synchronizing the cells of the
myocardium to produce a functional syncytium (5). Disruption in these
pathways, for instance, because of myocardium infarction, neuro-
muscular disorders, and spinal cord injuries, can have a detrimental ef-
fect on the tissue. A first hurdle in using organic bioelectronic devices as
conductive constructs in tissue engineering is that the CP component
would have to maintain its oxidized and electroactive state under phys-
iologically relevant conditions (6). Despite the potential of CPs in bio-
electronic devices, there is still a challenge of electronic stability required
over the lifetime of the implant. This challenge exists because CPs areknown to convert froman oxidized (conductive) to a neutral (noncon-
ductive) form upon exposure to air or when in contact with physio-
logical medium (7). Another hurdle for the application of some CPs is
their poor integration with the host tissue. However, there are some
notable successes showing that modulating or adding functionalities
in the construct, such as proteins, significantly enhances intimate con-
tact with tissue and thus integration (8–11). Here, we are interested in
addressing the electronic stability of CPs. We describe a novel fabri-
cation approach that immobilizes the “dopant” in the bioelectronic
device, generating a polyaniline (PANI) patch that is electronically stable
in physiological medium for more than 2 weeks. This finding clears a
major hurdle for using PANI, and potentially other CPs, in bio-
electronic devices over extended operational times.
The conductivity of CPs stems from a “doping” process through
which the polymer is exposed to oxidizing (p-type) or reducing (n-type)
agents known as dopants, which are capable of removing or adding
electrons to the polymeric backbone (7). Specific to PANI, a “proton-
doping process” was previously described, where the imine and amine
groups of the polymer become protonated upon treatment with a pro-
tonic acid; the end result is high conductivities, keeping the number of
electrons unchanged (fig. S1) (12). This doping process converts CPs
from an insulating state to a highly conductive state, and any perturba-
tion in the amount of dopant associated with the polymeric backbone
causes changes in the electrical properties of the polymer. Loss of dopant,
known as “dedoping,” following incubation under nonacidic or physio-
logical conditions is a severe limiting factor for the long-term use of
conjugated polymers in biological and medical applications (7). Signifi-
cant loss of dopant accompanied by a reduction in conductance occurs
from polypyrrole films within 2 days of incubation under physiological
conditions (13). Similarly, polythiophene-based biomaterials are
converted to the reduced form following incubation in cell culture me-
dium (14) or through exposure to air (15). A further challenge for PANI
is the deprotonation of amine groups caused by the neutral pH of bodily
fluid (16, 17). In a studybyGill et al. (18), a reduction in conductancewas1 of 13
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 directly related to the level of deprotonation of the PANI amine groups
that occurs in response to neutral or higher pH solutions.
Here, we describe a new fabrication process based on polymerizing
aniline in the presence of the dopant phytic acid on a prefabricated chi-
tosan film that meets the challenge of deprotonation. Taking advantage
of the multivalent anionic nature of phytic acid and the positively
charged amine groups on both the chitosan and the PANI backbone,
the PANI/chitosan patch is designed to retain the dopant and thus re-
mains in the conductive state, as we herein demonstrate by applying
different characterization techniques. Whereas chitosan is an insulator,
its use as a substrate is advantageous to produce a flexible andmechan-
ically robust freestanding conductive film without compromising the
electronic activity. The ease of the fabrication technique used is of sig-
nificance for the application of this film as a polymeric patch in tissue
engineering. This is in contrast to hard electronics, which have a signif-
icant mismatch in mechanical properties with tissue (1). Together with
the in vitro electronic biostability, this freestanding conductive patch
serves as a platform to interface with electroresponsive tissues such as
the heart. We investigated the effect of the patch on cardiac
electrophysiology using both cardiac slices and Langendorff-perfused
hearts. A further benefit of using the chitosan film is that it could be
applied to tissue without the need for sutures. Upon the addition of
Rose Bengal (RB), a photoactivated dye, the chitosan film can operate
as a bioadhesive (19, 20). The RB-chitosan film adheres to tissue
following irradiation with a green laser (l = 532 nm), avoiding the
more commonly used surgical suturing. Here, we used this technology
to produce a sutureless conductive patch that was implanted success-
fully in vivo for 2 weeks. o
n
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Fabrication of the PANI patch
The PANI patch was fabricated in a two-step procedure (Fig. 1, A and
B). First, chitosan solution was drop-casted on a glass slide to form a
well-defined film that was left to dry for 2 weeks. This drying process
is simple and scalable: No chemical modification is required for the fab-
rication of totally insoluble chitosan films (21, 22). The second step wasMawad et al. Sci. Adv. 2016;2 : e1601007 30 November 2016drop-casting the mixture of aniline, phytic acid, and ammonium per-
sulfate (APS) on the surface (23). The change in color from light brown
to green indicated the onset of aniline polymerization, which eventually
transformed to a thick layer of metallic green polymer on the surface.
After 3 hours, the reaction was quenched with water, and a superficial
layer of PANI was washed away, with only the PANI crosslinked to the
chitosan surface remaining. Phytic acid has six phosphonic acid groups
(PO3H2), and its proton dissociation falls in three regions (24), leading
to a negatively charged compound for pH >2. With its high number of
anions, phytic acid can protonate the amine groups on the chitosan
backbone (25) and also binds to the positively charged PANI (23).
The chitosan layer functions as a base membrane binding strongly to
phytic acid, which, in turn, bonds to the PANI chains, resulting in a
blended system with strong interactions between its three different
components. Ionically crosslinking the dopant phytic acid with both
chitosan and PANI has the advantage of creating a system with far
greater dopant stability.
In vitro characterization of the patch’s physical properties
The fabricated patch was peeled off the glass slide to produce a
freestanding patch with a thickness of 19.06 ± 3.36 mm, as determined
by scanning electron microscopy (SEM) (Fig. 1C), in comparison to
12.10 ± 2.07 mm for unmodified chitosan films. The thickness of the
patch can be easily tailored to suit different requirements by simply
changing the volume of the drop-casted chitosan solution. The micro-
scale topography of these patches imaged by optical profilometry (Fig.
1C) is uniform over a large surface area (117 mm × 156 mm; fig. S2),
indicating the suitability of the drop-casting technique to dispense the
phytic acid/aniline solution followed by its polymerization. The me-
chanical properties of the patch (Young’s modulus, 6.73 ± 1.14 MPa;
tensile strength, 5.26 ± 2.25 MPa; elongation at break, 79 ± 22%; Table
1) are comparable to values reported for other PANI composites, such
as poly(glycerol sebacate) containing 20 and 30% PANI (26). The con-
tact angle of the patch of 62.1 ± 1.4° suggests amoderate wettability (48°
to 62°) (27). In comparison to other PANI composites (28), the surface
of the patch exhibits a higher hydrophilicity because of the phosphonic
groups in phytic acid. M
arch 3, 2017Fig. 1. Schematic representationofpatch fabrication.Chemical components (A) and fabrication steps (B) used toproduce thePANI patch. RT, room temperature. (C) Top: SEM
micrograph of a cross section of the patch. Bottom: Surface topography of the patch recorded using optical profilometer.2 of 13
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 In vitro characterization of the patch’s electronic properties
Cyclic voltammetry.
Cyclic voltammetry was recorded in phosphate-buffered saline (PBS;
0.1 M, pH 7.4) at a scan rate of 25 mV·s−1 versus Ag/AgCl (3 M KCl)
(Fig. 2A). Immediately after washing, an obtained cyclic voltammo-
gram exhibited characteristic features of PANI, indicated by two redox
couples: a primary couple at 0.38 V (anodic) and 0. 28 V (reduction)
and a secondary couple at −0.20 and −0.05 V. Despite the fact that the
cyclic voltammetry was recorded in buffer (pH 7.4), its characteristics
are typical of PANI in pH <6.0 (29) because of the internal acidic
environment induced by the phytic acid molecule. After 1 day of in-
cubation in buffer, we noticed a slight increase in peak separation be-
tween the anodic and cathodic peaks of each redox couple, indicative
that charge transfer was becoming more difficult. At days 7 and 14,
only the primary redox couple appeared as expected at more alkaline
pH (fig. S3) (29), accompanied by a cathodic shift. Nevertheless, the
current remained stable over the whole incubation period in neutral
pH, unlike PANI films doped with conventional small acids that ex-
hibit negligible electrochemical redox activity at pH >4 due to loss of
dopant (30, 31). The electrochemical behavior observed for the patch
in PBS indicates that crosslinking a small multivalent dopant, such as
phytic acid, during the synthesis of PANI is a viable approach to
producing conductive materials that are electroactive under physiolog-
ically relevant conditions over extended periods of time. Although the
patch comprised a significant amount of the insulator chitosan (chitosan
film uncoated with PANI; surface resistivity, >102 megohms per square;
fig. S4), it appears that effective charge transport can occur through the
patch even in PBS as an electrolyte.
Surface resistivity.
To test how the surface resistivity of the patch variedwith incubation in
pH 7.4 as a function of time, patches were assembled into custom-
made chambers and their current-voltage (I-V) traces (two-probe) were
recorded when they were still in the dry state (surface resistivity, 7.93 ±
2.64 kilohms per square); this was followed by adding PBS and incu-
bating at 37°C. At different time points, the PBS was removed and the
patchwas gently blotted dry before the I-V curves were recorded.After
1 day of incubation, the surface resistivity doubled in value before stabi-
lizing (Fig. 2B). A further increase (five times the original value) was re-
corded at days 10 and 14 (35.85 ± 9.40 kilohms per square). The increase
in patch resistance was attributed to partial loss of dopant, which led to a
lower protonation level of PANI [as will be shown from x-ray photo-
electron spectroscopy (XPS) data]. Nevertheless, the system appeared
tohavemarkedly enhanced stability compared to other PANI-basedbio-
materials, which exhibited a several orders of magnitude increase in sur-
face resistivity after theywere exposed to buffer (~6megohmsper square
after 100 hours of incubation in cell culture medium) (32). Extending
the lifetime of PANI-based bioelectronics in the conductive form hasMawad et al. Sci. Adv. 2016;2 : e1601007 30 November 2016the potential to have a significant impact in bioapplications that require
prolonged electrical stimulation regimes, for instance, in cardiac regen-
eration (33). Here, the PANI patch is capable of withstanding trains
of electric pulses mimicking those of the adult heart (33, 34) for 2 weeks
in cell culture medium, with the patch as an anode and the Pt plate as
the cathode. As shown in Fig. 2C, from day 5 onward, the current gen-
erated remains constant for the whole duration of continuous stimula-
tion. By conditioning the patch in cell culture medium for 2 days,
similar electronic stability was verified by subjecting the patch to pulses
of ±0.5 V (Fig. 2D). The low surface resistivity exhibited by the patch
developed here allows this material to act as a conductor under physi-
ological conditions for at least 2 weeks.
UV-Vis spectroscopy.
For an understanding of the effect of incubation on the electronic struc-
ture of the patch, samples were incubated in PBS and their UV-Vis
spectra were recorded at predetermined time points (Fig. 2E). Changes
in the protonation and oxidation states of PANI could bemonitored by
observing three characteristic absorbance peaks: 320 nm (p-p*
transition of benzenoid group), 420 nm (polaronic shoulder), and 500
to 900 nm (polaron region). Of significance is the peak at 420 nm as-
signed to the emeraldine salt (fig. S1), the electrically conductive form of
PANI (29). The spectrumof the patch at fabrication showed a broad flat
peak in the region between 345 and 420 nm, suggestive of a doped
polymer (35). As expected, another broad peak appeared in the region
of 750 to 850 nm, which is typical of the emeraldine salt form. After
1 day of incubation, a distinct peak appeared at 330 nm and a shoulder
at 420nm.This suggested that the level of doping decreased as a result of
incubation in buffer, which agrees with the surface resistivity and
electric stimulation recordings at day 1. To assess the effect of longer
incubation times on the protonated state of the patch, we monitored
the peak at 420 nm (fig. S5A) and the shift of themaxima in the polaron
region between 500 and 900 nm (fig. S5B). As the incubation time
increased, a decrease in the 420-nm peak was observed. This was ac-
companied by a blue shift in the polaron region, which suggests that
the patch was converted from the emeraldine salt form to the emeral-
dine base (nonconductive) form. After 10 days in buffer, the polaron
region peak became centered at 650 nm (fig. S5B), suggesting that the
emeraldine base form becomes the dominant state of the patch. The
changes observed in the spectral characteristic peaks agree with changes
in both the cyclic voltammetry and the surface resistivity (Fig. 2, A and
B). The UV data suggest that the bulk of the patch maintained a pro-
tonated species after 2 weeks in buffer, as demonstrated by the presence
of the 420-nm peak in all measured spectra.
To investigate whether the resistance of the patch for complete de-
protonation in neutral buffer was due to our fabrication design of cross-
linking the dopant to a base material, we fabricated a polycaprolactone
PANI blend (PCL-PANI) dopedwith a conventional small acid, camphor
sulfonic acid (CSA) (36), and characterized its UV spectra (Fig. 2F) in
response to buffer.We chose this systembecausewe could drop-cast the
mixture to produce freestanding films of similar thickness to ours. At
fabrication, theUV spectra showed the typical characteristics of a doped
PANI: The polaron peak is centered at 740 nm along with a distinctive
peak at 420 nm corresponding to the emeraldine salt form of PANI.
After 1 day of incubation, the UV spectra showed that the PCL-PANI
film is completely converted to the emeraldine base form of PANI: The
420-nm peak disappeared, and there was a shift of the polaron peak to
625 nm. This is due to the leaching out of the dopant from the film as it
comes into contact with the buffer, which causes the PCL-PANI to con-
vert from a conductive to a nonconductive form in a very short timeTable 1. Physical properties of the PANI patch.Physical property Measured valueMechanical properties
Young’s modulus
Ultimate tensile strength
Elongation at break6.73 ± 1.14 MPa
5.26 ± 2.25 MPa
79 ± 22%Contact angle
Thickness62.1 ± 1.4°
19.06 ± 3.36 mm3 of 13
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 (<24 hours). This result confirms that our approach of crosslinking the
dopant with the polymers leads to a PANI patch that exhibits a conduc-
tive nature over extended periods (14 days versus 1 day) under physi-
ological conditions.
X-ray photoelectron spectroscopy.
XPSmeasurements were conducted to detect any changes in the oxida-
tion state and doping level of the patch that might have occurred as a
result of incubation in buffer. The C 1s, O 1s, N 1s, and P 2p core-level
spectra were analyzed at fabrication (day 0) and after 7 and 14 days of
incubation (Fig. 3 and fig. S6). The residing state of nitrogen in the
PANI backbone is of particular interest because its chemical
environment reveals the oxidation and protonation states of PANIMawad et al. Sci. Adv. 2016;2 : e1601007 30 November 2016(fig. S1) and can be related to the doping level induced by the addition
of acids (17, 35). To this effect, the relative amounts of protonated imine
and amine were estimated from curve-fitting the N 1s spectra (Fig. 3, A
to D). The chemical interactions in the patch led to the assignment of
fourN chemical environments: imine at ~398.2 eV, amine at ~399.7 eV,
oxidized amine (–NH+) at ~401.0 eV, and protonated imine (=NH+) at
~402.0 eV. Table 2 lists the percentage of each nitrogen species
calculated by comparing the peak area of individual nitrogen species
to the total N 1s area (37, 38).
All samples contained two species of the positively charged nitrogen,
–NH+ and ==NH+, which can be assigned as polaron and bipolaron
states, respectively, as previously reported (39). These positively chargedFig. 2. Electronic stability of PANI patchesdemonstrated in vitroover 2weeks of incubation (A to E) andUVspectrumofPANI-PCL film (F). (A) Cyclic voltammograms
(25 mV·s−1) in 0.1 M PBS reveal the stable electrochemistry. D, day. (B) Surface resistivity exhibits only a fivefold increase in value. Continuous electric stimulation (C and D)
reveals that the patch retains a constant current after 2 days of incubation in buffer. Ultraviolet-visible (UV-Vis) spectra of (E) the PANI patch and (F) PCL-PANI as a function of
incubation time in PBS (pH 7.4): The peak at 420 nmpersists in our PANI patch,whereas it disappears after 1 day of incubation in the PCL-PANI film, indicating conversion to the
nonconductive form. a.u., arbitrary units.4 of 13
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 species correlate to the doping level of PANI, and their relative amounts
varied as a function of incubation time. At fabrication, the patch exhib-
ited a doping level of ~18%, in agreement with doping levels reported
for electropolymerized PANI films (40) and PANI colloids prepared by
chemical oxidation in acidic medium (41). However, some PANI
systems have been reported to have higher doping levels (35), for in-
stance, as is the case for the PCL-PANI blends fabricated in this study,
with a doping level of ~40% (Table 2 and fig. S7). The lower doping level
in our patch is likely due to two factors. First, the patch has a lower dopant-
to-monomer ratio than PCL-PANI, and thus, one expects a lower amount
of dopant to be incorporated into the former. Second, strong inter-
molecular interactions canoccur between themultivalent anionphytic acidMawad et al. Sci. Adv. 2016;2 : e1601007 30 November 2016and the amine groups of chitosan (25) and therefore reduce the availability
of phytic acid as a dopant to PANI.Despite the lower protonation level, the
patch exhibits a high conductivity value of 0.162 ± 0.043 S/cm.
The ratio of the positively charged N decreased as incubation time
increased, which is consistent with the well-known deprotonation of
PANI in buffer (pH 7.4). However, after 2 weeks of incubation, the
patch retained ~12% of the protonated species. This result agreed with
the UV spectrum (day 14; Fig. 2E), which exhibits peak characteristics
corresponding to the emeraldine salt form of PANI. In comparison,
the PCL-PANI blend had decreased to only ~6% protonation within a
single week of incubation. We attribute the enhanced stability of the
protonated species in our patch to the multivalent anionic nature of
phytic acid and its ability to bind strongly to chitosan and PANI. In
contrast, CSA within the PCL-PANI blend has one negative charge
and can easily diffuse out of the film, as previously reported for similar
systems doped with conventional small-molecule acids (13).
Complementary information about the change in the level of doping
state in response to incubation was obtained by tracking the element
phosphorous (P). One P 2p chemical environment consisting of the
two spin-orbit split states (P 2p3/2 and P 2p1/2) was curve-fitted with a
spin-orbit splitting of 1.1 eV (Fig. 3, E toG). In agreementwith the trend
observed for the protonated species, its value decreased after incubation.
However, the detection of P after 14 days of incubation suggests that
some of the dopant was retained on the surface of the patch, explaining
the protonated species detected byXPS. By contrast,monitoring the sul-
fur component in the PCL-PANI films revealed that the dopant CSA
did not exist on the surface after 7 days in buffer (Fig. 3H), in agreement
with the loss of the protonated species (UV and XPS data). This result
agrees with that from Fonner et al. (13), who showed the disappearanceFig. 3. Detection of protonated species as a function of incubation time.High-resolution narrow scans of N 1s (A toD), P 2p (E and F), and S 2p (G) core-line spectra of the
PANI patch at fabrication (A and E) and incubated for 7 days (B and F) or 14 days (C and G) in buffer. N 1s (D) and S 2p (H) core-line spectra of PCL-PANI incubated for 7 days in
buffer. Peak heights are normalized to the peakmaxima of the N 1s (A to D) or P 2p (E to G) of the patch at fabrication (first column). Within each row, panels are on the same
arbitrary y axis.Table 2. Elemental ratios by XPS surface analysis.% N 1s signalIncubation
time
(days)=N− −NH −NH2
+ =NH+ P 2p3/2/C 1sS 2p3/2/
C 1sPANI patch0 6 77 12 6 0.0147 23 65 10 3 0.00314 21 68 9 3 0.004PCL-PANI
0 10 51 32 7.7 0.017 11 90 6 Negative Negative5 of 13
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 of small dopants, such as chloride and p-toluene sulfonate ions, from
electropolymerized polypyrrole films after 2 days of incubation in
PBS. Similar dopant loss has been shown by Mahat et al. (17).
The patch tested in an ex vivo cardiac model
The electronic biostability of the PANI patch under physiological
conditions points encouragingly to application with electroresponsive
tissues. An obvious application is the heart because many cardiac dis-
eases result in disruption of the electrical signal of the heart wall. Car-
diac patches have been shown to have a beneficial effect on cardiac
function and reconstruction of the damaged tissue (42). More recently,
there is emphasis on developing cardiac scaffolds that have the
potential to electrically couple with the heart. Conductive materials
used in the fabrication of these scaffolds include conjugated polymers
(26, 43, 44), carbon-based materials such as graphene/graphene oxide
(45, 46) and carbon nanotubes (47–49), and metallic nanoparticles or
nanowires such as gold (50). Introducing conductivity in these scaffolds
resulted in several benefits: enhanced electrical coupling (47, 48, 50),
higher rates of spontaneous beatings of cardiomyocytes cultured on these
scaffolds (46), and improved function of infarcted hearts (45, 49). Hav-
ing established that our patch sustains its electronic properties in vitro,
we set out to investigate in the first instance whether its attachment to
cardiac tissue will have any effect on the mechanical or electrophysio-
logical function. We conducted ex vivo examinations on both ultrathin
cardiac slices and whole hearts.
Cardiac slices.
Conductive patches (C-Patches) of different sizes were positioned on
cardiac slices, and the contractility of the tissue was measured in re-
sponse to field stimulation (Fig. 4A). Slices that had C-Patches of 9
and 17 mm2 in size (covering 22.5 and 42.5% of the slice surface area,
respectively) exhibited contractile forces comparable to those that had
no patch, which indicates that the slices remain electrically active upon
stimulation. However, as the C-Patch size was increased to 25 mm2
(covering ~63% of the slice surface area), a significant drop in the am-
plitude was observed (~21%, P < 0.05, n = 13). Subsequently, upon re-
moval of the patch, the slice showed complete recovery of contractility.
To confirm that this drop in contractility is not a mechanical effect in-
duced by the patch but rather due to its electronic properties, the con-
tractility of slices was measured in the presence of a nonconductive
patch (nC-Patch) with a similar Young’s modulus (6.99 ± 2.58 MPa).
The contractile forces were found to be comparable to the contractile
force of the slice before the nC-Patchwas added or after it was removed.
The effect of the conductive patch on the electrophysiology of the
heart slices was assessed using the multielectrode array (MEA) system
(51). The conduction properties were determined first for the heart slice
at baseline, followed by positioning the C-Patch (9 or 25 mm2) on the
top side of the slice, and finally after the C-Patch had been removed.
Figure 4B presents a summary of the average longitudinal and trans-
verse conduction velocities (CVL and CVT, respectively) obtained.
The slices exhibit a higher CVL than CVT, as expected, reflecting the
electrical anisotropy of the cardiac tissue. A significant drop in CVs was
observed for both CVL and CVT when the C-Patch was positioned on
the slice, irrespective of its size. The patch was removed, and an imme-
diate measure of the slice CV was recorded. In the case of CVL, the CV
of the slice was regained after C-Patch removal; however, this recovery
was not observed in the CVT.
Whole hearts.
Optical mapping experiments were conducted to probe the effect of
the C-Patch on the electrophysiology of whole hearts (Fig. 4, C to G)Mawad et al. Sci. Adv. 2016;2 : e1601007 30 November 2016(52, 53), studied ex vivo and taken from both healthy animals and
those in which a myocardial infarct (MI) had been induced by coro-
nary ligation, and allowed to develop for 2 weeks. Epicardial optical
mapping generated activation time maps, and subsequently CV maps,
of healthy (Fig. 4C) and MI hearts (Fig. 4D) before and after the
application of the patch. In agreement with the results obtained from
the slices, apical CV dropped significantly when the C-Patch was su-
tured to the healthy hearts (66.3 ± 4.3 cm/s to 47.8 ± 5.1 cm/s, P <
0.02, n = 5), whereas no significant effect on the CV was observed
following the attachment of nC-Patch. CV was significantly lower in
the infarcted hearts compared to the healthy hearts as expected, and this
was most pronounced in the apex (26.9 ± 2.7 cm/s versus 59.8 ± 4.7 cm/s,
respectively, P < 0.001, n = 10). The C-Patch increased CV in the apical
infarcted area (24.3 ± 4.9 cm/s to 30.1 ± 4.2 cm/s, P < 0.05, n = 5). The
change in CV was significantly different between healthy andMI hearts
after conductive patch application [P < 0.01, one-way analysis of var-
iance (ANOVA) with Dunn’s post hoc test]. Action potential duration
(APD) was only minimally affected by the presence of both types of
patches and is unlikely to have a role in the observed effects (fig. S8).
Therefore, attaching the C-Patch on either heart slices or whole
hearts has an effect on cardiac electrophysiology, whereas the nC-
Patch, an insulating material, did not interfere with the cardiac electric
activity. Although the exact mechanism is not elucidated at present,
this points to the exciting fact that it is the electroactive nature of
the patch, and not its mechanical effect, which is the factor in the ob-
served changes.
In vivo application of the patch
One could envision that the clinical application of the C-Patch may
require that the material be positioned on both healthy and damaged
tissue (as in Fig. 4D), in particular, if the patch is ultimately to be used
to manipulate the electrical properties of damaged areas of the heart.
Although patches are considered to have some advantages over inject-
able cells/hydrogel systems in that they retain more cells of the
delivered dose and provide structural support, their implantation on
the heart has always been looked at as challenging and complex (42)
and often requires invasive suturing techniques. Here, we introduced a
new sutureless method for adhesion of patches onto heart tissue
(movie S1), namely, using photoadhesion with a green laser (fig. S9
andmovies S1 and S2) (54, 55). Consequently, we conducted a prelim-
inary in vivo study to investigate whether the sutureless C-Patch has
any effect on cardiac function andwhether it imposes a proarrhythmic
risk. Furthermore, we wanted to test whether the photoadhesion was
effective in securing the patch onto a beating heart despite abrasive
effects from contents of the intrathoracic cavity.
Effect on cardiac function.
Echocardiography results showed that adhesion of the patches (both
nonconductive and conductive) had no significant effect on global
heart function (Fig. 5, A and B). A small but a significant increase
in the ejection fraction (EF) and fractional shortening (FS) of hearts
with C-Patches was observed in comparison to the sham group (Fig.
5B). This could not be ascribed to differences in chest wall adhesions
of the patch because the degree of adhesion was consistent between
the groups. The relaxation properties of the heart (left ventricular in-
ternal diameter in diastole, Fig. 5A) were unaffected by either patch.
This suggests that the patches, despite having a higher Young’s
modulus than typical adult myocardium, do not inhibit the contractile
properties of the heart. A series of experiments involving adminis-
tration of adrenaline (0.5 mg/kg, intraperitoneally) was conducted6 of 13
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 to examine whether the C-Patch predisposes to arrhythmia. Heart
rate increased in all groups after adrenaline injection (Fig. 5C), as
would be expected. However, this increase was comparable between
all four groups. Injection of adrenaline induced arrhythmic events
[ventricular ectopics, nonsustained ventricular tachycardia (VT),
VT, ventricular fibrillation (VF)] in all experimental groups. No sig-
nificant difference in arrhythmia score was observed between theMawad et al. Sci. Adv. 2016;2 : e1601007 30 November 2016four groups (Fig. 5D). These results suggest that patches applied
by photoadhesion that are conductive in nature do not influence the
proarrhythmic state of the heart under stress and may be safe in car-
diac application.
Sutureless application of the patch and immunohistology.
After 2 weeks in vivo, the patches remained adhered to the cardiac
tissue (fig. S9C), which indicated that photoadhesion is an effectiveFig. 4. Ex vivoand in vivocardiacevaluationof thePANI patch. (A) Contractility of the cardiac slices in response to field stimulation. (B) Conduction properties of cardiac slices
measured by MEA system. (C to G) Ex vivo whole-heart epicardial voltage mapping: Representative activation time and CV maps before (C) and after (D) conductive patch
application on healthy control hearts (C) and on hearts 2 weeks after MI (D) [permanent ligation of left anterior descending coronary artery (LAD)]. (E) CV in healthy andMI hearts
(n=10, *P<0.05, **P<0.001, ***P<0.0001). (F) NormalizedCV in healthy hearts before and after patch application (n=5, *P<0.05). (G) NormalizedCV inMI hearts before and after
patch application (n = 5, *P < 0.05). “Local basal”: average CV in basal half of the heart (noninfarcted area) calculated on a pixel-by-pixel basis from the activation timemaps; “Local
apex”: average CV in apical half of the heart (infarcted area); “Base to apex”: CV calculated across whole heart from pacing electrode to apex.7 of 13
SC I ENCE ADVANCES | R E S EARCH ART I C L E
 o
n
 M
arch 3, 2017
http://advances.sciencem
ag.org/
D
ow
nloaded from
 technology (movie S2) to apply patches to the heart in a potentially
less invasive manner. It is reported in the literature that the adhesion
is due to a photocrosslinking mechanism between biomolecules ini-
tiated by the activation of RB into an excited state (56, 57). Further
investigations involving spectroscopy techniques are needed to eluci-
date the exact molecular mechanism underlying the bonding between
chitosan films and tissue via green lasers. To examine the interaction
of the patch with the myocardial surface, histology was performed
2 weeks after implantation (figs. S10 and S11). Both the C- and nC-
Patches were surrounded by a cellular infiltrate, which continued
around the heart, decreasing in thickness in relation to the distance
from the patches (fig. S10, A to D). The thickness of encapsulation
was comparable between both patches, as shown in fig. S11E. Similar
thickness has been reported for a porous poly(glycerol sebacate) scaf-
fold tested as a cardiac patch after 4 weeks of implantation (58).
Immunostaining for vimentin and CD45 (fig. S10, H and I) revealed
that the cell population was composed of fibroblasts (vimentin+) and
inflammatory cells (CD45+). In the fibrotic tissue surrounding the
patch, there was some neovascularization indicated by von Willebrand
factor staining (fig. S10, E toG). Although the patches were not in direct
contact with the myocardium, the surface appeared undamaged be-
cause the border myocardium/scar was well defined and the myocytes
in proximity to the fibrotic scarwerewell organized (fig. S10, L toN, and
fig. S11). This also indicates that the laser irradiation used for photo-
adhesion at the time of implantation did not cause damage to the car-
diac tissue. Photoadhesion using RB either as a solution or embedded inMawad et al. Sci. Adv. 2016;2 : e1601007 30 November 2016a biomaterial, such as chitosan, has been extensively applied in vitro and
in vivo without any adverse reactions or cytotoxicity effect on the
surroundings (19, 54, 55). In addition, photoadhesion using RB has
been tested in a clinical trial that included 27 patients (59), withminimal
inflammation reported during the early healing process, attributing this
to a lack of phototoxicity (60). Sham controls showed only a limited
cellular expansion of the epicardium in comparison to control rats
(fig. S10, A, B, E, F, L, and M). Smooth muscle actin expression is a
well-known marker for fibroblast activation and differentiation into
myofibroblasts; cells expressing this marker were noticed in the en-
capsulation of the heart and in near proximity to both the C- and
nC-Patches (fig. S10, J and K). It is clear that, for the C-Patch to be po-
tentially applied as a cardiac patch, design strategies targeting the
material-cell interface should be developed to modulate the immune
response, such as the loading of anti-inflammatory mediators or alter-
ation of the surface topography and roughness (61). Integration of con-
ductive scaffolds has been successfully shown in the literature (8–11),
and this should inspire futurework to enhance the adhesion of the patch
to biological tissues.CONCLUSIONS
In summary, we have shown that, by immobilizing the dopant in the
conductive construct, enhanced electronic stability under physiologi-
cally relevant conditions can be achieved. After 2 weeks of incubation
in buffer, the patch exhibited stable electrochemistry and relatively lowFig. 5. Echocardiographic assessment of cardiac function and arrhythmia provocation 2 weeks after patch implantation. (A) Left ventricular dimensions. (B) Left ven-
tricular function (n=5; *P< 0.05). IVS, interventricular septum; LVID, left ventricular internal diameter; LVPW, left ventricular posterior wall; d, diastole; s, systole. (C andD) Ratswere
given two intraperitoneal injections of adrenaline (0.5mg/kg) to induce arrhythmias, with the electrocardiogram (ECG) recorded for 30min after each injection. (C) Average heart
rate (HR) over 10 min recorded before adrenaline injections (baseline) and 20 min after the second adrenaline injection. (D) Each animal is assigned an arrhythmia inducibility
score: 0 = no arrhythmias; 1 = only minor events such as premature ventricular contractions (PVCs), couplets, and triplets; 2 = more severe events such as nonsustained VT,
sustained VT, and VF.8 of 13
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aldine salt form of PANI. These results were further confirmed by
XPS, which revealed the presence of protonated species on the surface
over the incubation period. New insights into the effect of conjugated
polymers at the interface of cardiac tissue have been obtained by ap-
plying the conductive patch in ex vivo cardiac models. An interesting
observation was the effect of the conductive patch on the CV of the
heart, lowering its value in healthy models while increasing it in in-
farcted hearts. Future work should focus on unraveling the mecha-
nism behind this effect. In vivo studies indicated the safe sutureless
application of the C-Patch on cardiac walls. The stability of this patch
in the conductive state under physiological conditions and its demon-
strated effect on cardiac electrophysiology sets the foundation for the
design of electronically stable CP-based scaffolds that could effectively
function as electronic interfaces. Significantly, this study presents a
robust bioelectronic device that, because of its electronic stability, could
potentially be applied at the biotic-abiotic interface to elucidate the role
of conductive materials in electroresponsive tissues in both ex vivo and
in vivo models. o
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 MATERIALS AND METHODSMaterials
Chitosan (medium molecular weight, 85% deacetylation), RB, ani-
line, phytic acid [50 weight % (wt %) in water], APS, PCL, CSA, hexa-
fluoroisopropanol, acetic acid, and phosphate buffer tablets were all
purchased from Sigma-Aldrich and used without further purification.
Chemicals for the ex vivo experiments were purchased from either
VWR International or Sigma-Aldrich.
Experimental methods
Fabrication of PANI patch.
ThePANI patches (C-Patch)were fabricated by first preparing a chitosan
film followed by the polymerization of aniline on the film surface in the
presence of phytic acid as a dopant (23). In a typical procedure to produce
the nC-Patch, chitosan films were prepared, as described by Lauto et al.
(19), without the addition of RB. Chitosan (medium molecular weight,
85% deacetylation) was dissolved at 1.8 wt % in 2% (v/v) acetic acid
solution. The solution was centrifuged at 4000 rpm for 5 min to get
rid of any insoluble flakes. Chitosan solution (1.6ml) was evenly spread
on a microscope slide (7 cm × 2 cm) and left to dry for 2 weeks at at-
mospheric pressure. To prepare a C-Patch (1 cm × 1 cm), two solutions
were prepared. Solution 1 contained phytic acid (2.30 ml) and aniline
(1.15 ml) in deionized water (DI H2O) (5 ml). Solution 2 contained the
oxidant APS (1.42 g) in DI H2O (5 ml). Varying the molar ratio of an-
iline to the dopant or aniline to the oxidant resulted in no significant
change in surface resistivity (see table S1). The two solutions were left
in the refrigerator for 30min before use. Solutions 1 (77 ml) and 2 (23 ml)
were mixed in an Eppendorf tube, vortexed, and then dispensed on the
surface of the chitosan film. The solution was allowed to polymerize on
the surface for 3 hours. To quench the polymerization reaction, patches
were rinsed with DI H2O thoroughly until no PANI flaked off the sur-
face. Patches were then incubated in DIH2O overnight to wash out any
excess phytic acid, uncrosslinked polymeric chains, and any side
products. Patches were then peeled off the glass slide, blow-dried with
N2, and stored between two glass slides tomaintain their flat shape. Care
was taken to ensure that the top side of the patch was properly identi-
fied. All characterizations were done on the top side of the patch. Blends
based on PCL and PANI doped with CSA were fabricated according toMawad et al. Sci. Adv. 2016;2 : e1601007 30 November 2016the procedure described in the literature (36). To obtain films of com-
parable thickness to the PANI film, 1.6 ml of the PCL-PANI solution
was evenly spread on a glass slide (7 cm×2 cm) and left to dry for 2 days
at room temperature. For the in vivo experiments, the C-Patches con-
tainedRBneeded for photoadhesion. RB (0.1 wt%)was dissolved in the
chitosan solution, and the same procedure was repeated as described
above. The geometry of these patches is shown in fig. S9C.
Characterization of physical properties.
The thickness was determined by imaging the edges of the patches (n =
5) using SEM operated at 15 kV. The mechanical properties were
determinedusing a calibrated single-column tensiometer thatwas inter-
faced with a PC (Instron). Patches (3 mm × 5 mm, n = 10) were kept
moist before the tensile test tomimic in vivo conditions. Opposing ends
of each samplewere clamped to the tensiometer usingmechanical grips,
which moved at a rate of 10 mm/min until the patch broke. The max-
imum load at which the patch broke was recorded with Merlin IX
software. The surface roughness of the patch was assessed using a light
interferometry profilometer (GTK1-M Contour, New Spec). Three-
dimensional images of the PANI patch were obtained using a 20× ob-
jective in vertical scanning interferometrymode. The surface wettability
for the PANI patch (n = 5) was measured using the sessile drop tech-
nique (Ramé-Hart Instrument Co.), and the advancing contact angle
was determined using DROPimage Standard software analysis.
Electronic characterization.
Cyclic voltammetry measurements were recorded using a CHI660D
instrument. The counter electrode was a platinum mesh, and the
reference electrode was Ag/AgCl in saturated KCl aqueous solution
(CHI Instruments). The working electrode was gold-coated Mylar
(VacuLayer Corp.) on which the patches were fabricated. Electro-
chemical measurements were performed at a scan rate of 25 mV·s−1
using 0.1MPBS aqueous electrolyte solutions. Conductivity of dry films
was measured by recording four-probe dc electric measurements using
the Keithley 2400 SourceMeasure Unit coupled to a digital multimeter
(Agilent 34401A).
To monitor the stability of the PANI patches during incubation in
PBS, their surface resistivity was determined at different time points.
Rectangular samples (length, 3 cm; width, 0.5 cm; n= 3)were fabricated
and mounted in custom-made chambers. The chamber (diameter,
1 cm) was filled with PBS. Flat electrodes of gold-coated Mylar were
pressed at the edges of the well (1.2 cm apart). The gold electrodes were
connected to a source-measuring unit, and the I-V characteristics of the
patches were recorded by sweeping the voltage at ±1 V. The surface re-
sistivity (r) was calculated according to Eq. 1
r ¼ w
L
R ð1Þ
where R is the resistance of the patch calculated from the slope of V
versus I,w is thewidth of the film (0.5 cm), andL is the distance between
the two electrodes (1.2 cm).
To test the electronic stability of the patch in physiological medium,
samples fabricated on gold Mylar were assembled in the custom-made
chamber filled with PBS and used as the anode. A platinum plate was
used as the cathode. A rectangular pulsed regime of 0.1 V, 2 ms at 1 Hz
was applied for 2 weeks or a regime of bipolar pulses of ±0.5 V was
applied for 1 week using a Stanford Research Systems DS345 function
generator. The output voltage and current through the film were
measured using a Rigol DS1052E digital oscilloscope, with the current
converted to voltage by a Femto DLPCA-200 preamplifier. For cases9 of 13
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 where the resistance of the patch was low enough to approach the
output impedance of the signal generator, custom-made voltage
dividers tailored to each particular patch were used to increase the cir-
cuit resistance.
UV-Vis measurements.
PANI patches (n = 4) were fabricated as described above, except for the
polymerization time, which was decreased from 3 hours to 5 min to
obtain films with reduced opacity, allowing for the transmission of
the UV beam. Samples were prepared on glass slides (4 cm × 1 cm)
and incubated in a 3-ml cuvette containing PBS. Their absorption
spectra were recorded at predetermined time points with a PerkinElmer
Lambda 25 UV/Vis spectrophotometer in the range between 300 and
900 nm.
X-ray photoelectron spectroscopy.
XPS spectra were obtained on a Thermo Fisher K-Alpha spectrometer
using a monochromatic Al-Ka x-ray source (energy, 1486.71 eV), with
an electron takeoff angle normal with respect to the analyzer. A low-
energy electron/ion flood gun was used to ensure effective surface
charge compensation. Survey spectra in the range of 0 to 1300 eV
were recorded for each sample (pass energy, 200 eV) followed by high-
resolution measurements (pass energy, 50 eV) for C 1s, N 1s, S 2p, P 2p,
and O 1s core levels. Despite the use of the electron flood gun, some mi-
nor charging was seen; therefore, spectra were calibrated to the adventi-
tious C 1s signal (284.6 eV).
Curve fitting of high-resolution spectra was carried out using Thermo
Scientific Avantage (version 5.948) with Shirley background corrections.
The amine peakwas fixed at 399.2 eV, whereas the positions for the other
peaks were variable; however, reasonable peak fits had imine, protonated
amine, and protonated imine located at≈398.3,≈400.8, and≈402.1 eV,
respectively. Curve fits used pseudo-Voigt functions, which are the pro-
duct of Lorentzian and Gaussian line shapes, with the percentage of the
Lorentzian component variable between 0 and 15%. The full half-width
maximum was constrained to be between 1.2 and 2 eV. Peak areas were
normalized within the Avantage software using atomic sensitivity factors
(62, 63), and from these areas, nitrogen composition, the level of doping,
and elemental ratios were determined.
Preparation of viable myocardial slices.
Rat left ventriclemyocardial slices were prepared using a high-precision
vibrating microtome (7000smz, Campden Instruments Ltd.), as de-
scribed by Camelliti et al. (51). The 300-mm-thick slices were kept in
cold (4°C) and oxygenated (100% O2) Tyrode’s solution (140 mM
NaCl, 6 mM KCl, 10 mM glucose, 10 mM Hepes, 1 mM MgCl2, and
1.8 mM CaCl2; pH 7.4) containing the excitation-contraction uncou-
pler 2,3-butanedione monoxime (BDM; 10 mM). Electrophysiological
and contractility recordings were performed in 37°C BDM-free KCl
(4.5 mM) Tyrode’s solution.
Contractility.
To measure the contractility of stretched myocardial slices,
polytetrafluoroethylene-coated silver wire rings were attached to the
edges of 300-mm-thick slices perpendicular to the muscle fiber orien-
tation. The samples were then stretched, and the contractility was
measured using the HSE isometric force transducer F10 (Hugo-Sachs
Electronik/Harvard Apparatus). Force measurements were taken on
myocardial slices (n = 13); the patches were then positioned on the sur-
face of the slice and removed after the recordings were taken. Different
sizes of C-Patches [9 mm2 (n = 3), 17 mm2 (n = 4), and 25 mm2 (n =
13)] and one single size of nC-Patch [25 mm2 (n = 8)] were assessed
on the same cardiac slice. Data are shown as values normalized to the
contractility of the slice before the patches were applied.Mawad et al. Sci. Adv. 2016;2 : e1601007 30 November 2016Multielectrode array.
Noninvasive synchronousmultifocal recording of extracellular field po-
tentials of myocardial slices was studied using a MEA system
(MEA1060, Multichannel Systems). The heart slices were positioned
in the center of the MEA dish, and the patches were positioned on
the surface of the slice and held in contact by a slice holder. The samples
were continuously superfused with oxygenated Tyrode’s solution at
37°C, and bipolar pulses of 1 to 5 V (frequency of 1 Hz) were applied
to electrically stimulate the slices (n = 7) from different MEA micro-
electrodes located around the edge of the preparation. Thiswas followed
by stimulating the slices withC-Patches of different sizes [9mm2 (n= 8)
and 25 mm2 (n = 6)] positioned on top. C-Patches were then removed,
and the slices (n= 7)were subjected to stimulation again. Field potential
recordings were processed to generate activation maps and to measure
CV using MC_Rack Software and MATLAB. We refer to CVL and
CVT as the maximum and minimum CV correlated with the muscle
fiber direction.
MI surgical procedure.
All animal procedures were carried out in accordance with the U.K.
Home Office Animals (Scientific Procedures) Act 1986 and Directive
2010/63/EU of the European Parliament on the protection of animals
used for scientific purposes and approved by the Imperial College Gov-
ernance Board for Animal Research. Adult male Sprague-Dawley rats
(250 to 350 g) were used in this study (n = 20). Rats were subjected to
acute MI induced by ligation of the LAD. Induction of anesthesia was
performed in an induction chamberwith 5% isoflurane/95%oxygen.Rats
were then intubated, and anesthesia was maintained during surgery
with 2% isoflurane/98%oxygen. Rats were given perioperative analgesia
[buprenorphine (0.05 to 0.1 mg/kg) and Rimadyl (5 mg/kg)], prophy-
laxis [Baytril (5 mg/kg)], and 1 ml of 0.9% saline administered sub-
cutaneously. A left parasternal incision followed by a thoracotomy
through the fourth intercostal space and removal of the pericardium
allowed visualization of the heart. Ligation of the LAD was performed
1 to 2 mm distal to the inferior border of the left atrium using an 8-0
Prolene suture. Effective ligation was confirmed by blanching and cya-
nosis of the left ventricular free wall and apex. The thoracotomy and
chest wall were closed using 4-0 coated Vicryl sutures, and the skin
was closed using 4-0 EthibondExcel sutures. Ratswere given daily doses
of Rimadyl (5mg/kg) for at least 48 hours after surgery. Twoweeks after
LAD ligation, the hearts were explanted and used for whole-heart
optical mapping experiments.
Whole-heart optical mapping.
To assess the effect of applying a conductive material to the surface of
the heart, we used an ex vivo whole-heart epicardial voltage mapping
technique to investigate electrical propagation across the epicardium.
Optical mapping was carried out on healthy hearts and those that had
undergone myocardial infarction 2 weeks previously. The heart was
rapidly explanted and rinsed free of blood in ice-cold oxygenated
Krebs-Henseleit solution (119 mM NaCl, 4.7 mM KCl, 0.94 mM
MgSO4, 1 mM CaCl2, 1.2 mM KH2PO4, 25 mM NaHCO3, and
11.5 mM glucose and equilibrated with 95% O2 + 5% CO2) containing
heparin (12 U/ml). The heart was transferred to a Langendorff appa-
ratus, where the aorta was cannulated and the heart was retrogradely
perfused with oxygenated Krebs-Henseleit solution.
Theheartwasperfused at a fixed flowrate (15ml/min) inside aperspex
optical mapping chamber. Following a 15-min stabilization period, the
heart was stained with the potentiometric dye 4-(2-(6-(dibutylamino)-2-
naphthalenyl)ethenyl)-1-(3-sulfopropyl)pyridinium hydroxide [di-4-
ANEPPS; 30 ml of di-4-ANEPPS (1 mg/ml) in dimethyl sulfoxide]10 of 13
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 and perfused with the excitation-contraction uncoupler blebbistatin (10
mM) to eliminate motion artifact. The heart was excited using 530-nm
light-emitting diodes, and emitted light was collected using a
complementary metal oxide semiconductor camera. Signals were re-
corded during pacing from the base of the left ventricular free wall
(400 beats per min; 1 mA). Action potentials were recorded with no
patch on the heart and after the C- or nC-Patch was sutured on. The
patches were sutured on with 8-0 Prolene sutures using the minimum
number of sutures required to ensure good contact between thematerial
and the epicardial surface.
Optical mapping data analysis.
The voltage signal characteristics, including activation time and CV,
were extracted using a bespoke MATLAB script. The raw signals were
mean-subtracted and inverted, and peaks were detected using a
threshold partially set by the user. APD50, APD70, APD90, etc., were
calculated as the time between the start of activation to the point on
the relaxation slope that corresponded to 50%, 70%, 90%, etc., of the
relaxation from the peak value down to the value at the start of the
activation (back down to baseline). The conduction velocity was
calculated based on methods published by Laughner et al. (52).
Sutureless application of the patch in vivo.
All experiments were performed in accordance with theU.K.HomeOf-
fice regulations, as stated above. Animals were observed in the operating
theater for anhour, following recovery fromgeneral anesthesia, atwhich
point any signs of pain or distress were acted upon in accordance with
HomeOffice regulations. Animals were checked twice a day for the first
three postoperative days during which analgesia and antibiotics were
given. They were weighed daily for the first week to pick up subtle signs
of failure to thrive and continued to be checked once a day thereafter.
Male Sprague-Dawley rats between 250 and 350 g were used for all
experiments (n = 20). Induction of anesthesia was achieved, with the
animal placed in an induction chamber and using the inhalation an-
esthetic agent isoflurane at 3 to 5% with oxygen flow at 3 liters/min.
The animal was shaved over the anterolateral aspect of the left chest
wall and replaced into the chamber. Once adequate anesthesia was
confirmed by assessing pedal reflexes, muscle tone, and respiratory
rate, the animal was then intubated using a 16-gauge cannula and
mechanically ventilated via a rodent ventilator. It was placed supine
on a draped heat mat, with its outstretched limbs taped and its body
temperature maintained at about 37°C. Maintenance of anesthesia
was achieved with isoflurane at 1.5 to 2% and oxygen flows of 0.4
to 0.5 liter/min. Heart rate and oxygen saturation were monitored
throughout the procedure using a rodent pulse oximeter connected
to its foot. The animal was prepped with povidone-iodine, and a sterile
field was achieved using transparent nonadhesive drapes. Intraoperative
pain relief consists of a single subcutaneous dose of Vetergesic
(buprenorphine) at 0.12 mg/kg. Adequate hydration was achieved by
giving 1-ml bolus of warm saline subcutaneously before an incision
was made. A left anterolateral incision was made over the fourth
rib, and a thoracotomy was achieved by cutting through the intercostal
muscles. The ribs were spread with a self-retaining retractor to expose
the beating heart. The parietal pericardium was excised, and the left
ventricle was partially extruded from the thoracic cavity. The patch
was placed over the left ventricular free wall and secured in place using
laser technology (movie S1) (54, 55). Briefly, the area of the patch
without PANI was irradiated by a diode-pumped solid-state laser
(CNI Lasers). The laser system has a multimode optical fiber (core
diameter, 200 mm) inserted into a handheld probe to provide easy
and accurate beam delivery. The laser was irradiated at a power ofMawad et al. Sci. Adv. 2016;2 : e1601007 30 November 2016170 ± 8 mW at 532 nm in a continuous wave with a beam spot di-
ameter on tissue of ~0.6 cm. The C-Patch was spot-irradiated for a
total time of 180 ± 9 s to deliver an average fluence of 110 J/cm2
(19). The nC-Patch was irradiated using the same power and fluence.
Laser eye protection goggles were worn during this part of the
procedure. The heart was allowed to drop back into the chest cavity,
and the lungs were inflated. The ribs and muscle layers were reap-
proximated using 5-0 Vicryl Rapide sutures, and the skin was closed
using a subcuticular approach with 4-0 Monocryl. Isoflurane was
turned off, and the animal was allowed to wake while gradually low-
ering the minute ventilation to stimulate intrinsic ventilatory effort.
Postoperative analgesia was achieved by subcutaneously injecting car-
profen (Rimadyl) at 5 mg/kg at the end of the operation and once
daily for 2 days. Antibiotic cover consisted of enrofloxacin given sub-
cutaneously at 1 mg/kg at the end of the operation and daily for 2 days.
The animal was then placed in the recovery chamber until full recov-
ery. The procedure took about 1.5 hours.
Echocardiography.
Anesthetized rats were maintained on 1.5% isoflurane. Transthoracic
echocardiography was performed by a blinded examiner using a Vevo
2100 (VisualSonics) system. Two-dimensional andM-mode cine loops
of a long-axis view and a short-axis view at midlevel of the papillary
muscles were recorded. Left ventricular dimensions, FS, and EF were
calculated from the M-mode.
ECG and arrhythmia provocation.
Anesthetized rats were maintained on 1.5% isoflurane. ECG was re-
corded using LabChart Pro software and a PowerLab data acquisition
system. It is recorded from needle electrodes inserted subcutaneously
into the right forelimb and left hind limb. Body temperature was
monitored using a rectal probe andmaintained at 37°C using an adjust-
able heat pad. Baseline ECG recording was taken for 15 min. The rat
was given an intraperitoneal injection of adrenaline (0.5 mg/kg), and
ECG was recorded for 30 min. If no terminal arrhythmia was induced,
a second intraperitoneal injection of adrenaline (0.5 mg/kg) was given,
and ECG was recorded for a further 30 min. Arrhythmia events were
counted according to type (atrial ectopic, ventricular ectopic, couplets,
triplets, nonsustained VT, and VF), and each rat was assigned an ar-
rhythmia inducibility score (0 = no arrhythmic events; 1 =minor events
such as PVCs, couplets, and triplets; 2 = major events such as nonsus-
tained VT, sustained VT, and VF). Heart rate variability was analyzed
using the LabChart ProHRVadd-onwith the exclusion of ectopic beats.
Baseline heart rate is the average heart rate over the 10 min preceding
the first adrenaline injection. The heart rate after adrenaline is taken as
the average heart rate over the final 10 min of the procedure.
Histology and immunohistochemistry.
For histological staining, cross sections (20 mm) of isopentane-frozen
hearts were air-dried and fixed for 5 min in ice-cold acetone before
staining with hematoxylin and eosin. Microscopy was performed with
a Zeiss Axio Observer inverted wide-field microscope. Immunostain-
ing was performed on 20-mm frozen sections, and the samples were
fixed for 5 min in ice-cold methanol and permeabilized for 30 min in
PBS with 0.5% Triton X-100. The sections were incubated in blocking
solution [1% (w/v) BSA] at room temperature for 1 hour and then
were sequentially incubated with primary antibody at 4°C overnight
and secondary antibody for 1 hour at room temperature in the dark.
Between each staining, the samples were washed three times in PBS
(10 min each). Vectashield mounting medium with 4′,6-diamidino-2-
phenylindole was used to mount the samples on glass slides that were
then stored in slide boxes wrapped in aluminum foil at 4°C. The11 of 13
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oimages were collected using a Zeiss LSM-780 inverted confocal micro-
scope. The antibodies used for immunohistochemistry are summarized
in table S2. To quantify the foreign body response to the patches, the
size of the cellular capsule was measured. Sections of heart and
attached patch at the midmyocardium were stained with PicroSirius
red to visualize collagen and Fast Green (Abcam) to label cells and then
imaged for analysis. This stain distinguished the healthy myocardium
from the fibrotic cellular capsule. The thickness of the capsule was
measured at several points, and the width of the ventricle wall was in-
cluded for comparison.
Statistics.
Data are expressed as means ± SE. Unpaired and paired t tests were
used as appropriate. One-way ANOVA with Tukey post hoc test was
used for comparisons of multiple groups. Data that were not normally
distributed were compared using a Kruskal-Wallis test with Dunn’s
post hoc test. Values of P < 0.05 were considered significant.http://advances.sciencem
ag.or
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Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/2/11/e1601007/DC1
table S1. Solutions of aniline, phytic acid, and APS containing different molar ratios of aniline
to either the dopant or the oxidant.
table S2. Primary and secondary antibodies, dilutions, and suppliers.
fig. S1. Different forms of PANI.
fig. S2. Surface topography imaged by optical profilometer.
fig. S3. Cyclic voltammetry at days 1 and 14 of incubation.
fig. S4. I-V curves of chitosan and PANI patch.
fig. S5. Changes in absorbance at 420 nm and the shift in the polaron region.
fig. S6. XPS surface analysis of PANI patch at fabrication.
fig. S7. XPS surface analysis of PANI-PCL film at fabrication.
fig. S8. Apical and basal APD after cardiac patch attachment ex vivo.
fig. S9. Schematic presentation of the sutureless patch application.
fig. S10. Representative histological images of patches after 2 weeks in vivo.
fig. S11. Representative histological images at different magnifications of patches after
2 weeks in vivo.
movie S1. The procedure of the in vivo photoadhesion of the PANI patch using a green laser.
movie S2. Strength of the sutureless adhesion after ex vivo photoadhesion to heart tissue. o
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